These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26496681)

  • 1. Severe case of fetal hemolytic disease caused by anti-C(w) requiring serial intrauterine transfusions complicated by pancytopenia and cholestasis.
    Macher S; Wagner T; Rosskopf K; Reiterer F; Csapo B; Schlenke P; Klaritsch P
    Transfusion; 2016 Jan; 56(1):80-3. PubMed ID: 26496681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations: a case report and a review of the literature.
    Al Riyami AZ; Al Salmani M; Al Hashami S; Al Mahrooqi S; Al Hinai S; Al Balushi H; Al Riyami N; Gowri V; Al Dughaishi T; Al Hosni S; Al-Khabori M; Al-Farsi K; Al Huneini M; Alkindi S
    Transfusion; 2014 Jan; 54(1):238-43. PubMed ID: 23829228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe hemolytic disease of the newborn due to anti-Cw.
    Byers BD; Gordon MC; Higby K
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1180-2. PubMed ID: 16260563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial blood donations for intrauterine transfusions of severe hemolytic disease of the newborn with the use of recombinant erythropoietin in a pregnant woman alloimmunized with anti-Ku.
    Lydaki E; Nikoloudi I; Kaminopetros P; Bolonaki I; Sifakis S; Kikidi K; Koumantakis E; Foundouli K
    Transfusion; 2005 Nov; 45(11):1791-5. PubMed ID: 16271105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe intrauterine hemolysis due to anti-C(w).
    Chu HP; Kanagalingam D; Chan DK
    Am J Perinatol; 2007 Nov; 24(10):623-6. PubMed ID: 17972235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twin pregnancy complicated by severe hemolytic disease of the fetus and newborn due to anti-g and anti-C.
    Trevett TN; Moise KJ
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1178-80. PubMed ID: 16260562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of severe hemolytic disease of the fetus and newborn: a 10-year nationwide retrospective study.
    Sainio S; Nupponen I; Kuosmanen M; Aitokallio-Tallberg A; Ekholm E; Halmesmäki E; Orden MR; Palo P; Raudaskoski T; Tekay A; Tuimala J; Uotila J; Stefanovic V
    Acta Obstet Gynecol Scand; 2015 Apr; 94(4):383-90. PubMed ID: 25603954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
    Ree IMC; Lopriore E; Zwiers C; Böhringer S; Janssen MWM; Oepkes D; De Haas M
    Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of anti-Jka alloimmunization.
    Franco A; Rossi K; Krugh D; O'Shaughnessy R
    J Reprod Med; 2009 Mar; 54(3):121-5. PubMed ID: 19370894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged anemia in an intrauterine-transfused neonate with Rh-hemolytic disease: no evidence for anti-D-related suppression of erythropoiesis in vitro.
    Dorn I; Schlenke P; Härtel C
    Transfusion; 2010 May; 50(5):1064-70. PubMed ID: 20003047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal hemolytic disease due to anti-Rh17 alloimmunization.
    Hirose M; Nakanishi K; Kaku S; Moro H; Hodohara K; Aotani H; Takebayashi K; Noda Y
    Fetal Diagn Ther; 2004; 19(2):182-6. PubMed ID: 14764967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation.
    Verduin EP; Schonewille H; Brand A; Haasnoot GW; Claas FH; Lindenburg IT; Lopriore E; Oepkes D; Roelen DL; Doxiadis II
    Transfusion; 2013 May; 53(5):939-47. PubMed ID: 22924899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal hemolytic anemia and intrauterine death caused by anti-M immunization.
    Wikman A; Edner A; Gryfelt G; Jonsson B; Henter JI
    Transfusion; 2007 May; 47(5):911-7. PubMed ID: 17465958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemolytic disease of the fetus and newborn owing to anti-U, successfully treated with repeated intrauterine transfusions.
    Strindberg J; Lundahl J; Ajne G
    Immunohematology; 2013; 29(2):51-4. PubMed ID: 24094236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fetal hemolytic disease in a patient immunized by six antibodies: diagnosis and treatment].
    Tantalo V; Rossi E; Gianotti GA; Morotti R; Zuliani G; Buscaglia M; Galligani M
    Ann Ostet Ginecol Med Perinat; 1990; 111(5):321-5. PubMed ID: 2092607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolytic Disease of the Fetus and Newborn: Modern Practice and Future Investigations.
    Hendrickson JE; Delaney M
    Transfus Med Rev; 2016 Oct; 30(4):159-64. PubMed ID: 27397673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn.
    Moise KJ; Ling LE; Oepkes D; Tiblad E; Verweij EJTJ; Lopriore E; Smoleniec J; Sachs UJ; Bein G; Kilby MD; Miller RS; Devlieger R; Audibert F; Emery SP; Markham K; Norton ME; Ocón-Hernández O; Pandya P; Pereira L; Silver RM; Windrim R; Streisand JB; Leu JH; Mirza A; Smith V; Schwartz LB; Tjoa ML; Saeed-Khawaja S; Komatsu Y; Bussel JB;
    N Engl J Med; 2024 Aug; 391(6):526-537. PubMed ID: 39115062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Vel alloimmunization and severe hemolytic disease of the fetus and newborn.
    Moise KJ; Morales Y; Bertholf MF; Rossmann SN; Bai Y
    Immunohematology; 2017 Dec; 33(4):151-154. PubMed ID: 29378146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.